Cholesterol-lowering drugs called statins have the potential to reduce heart disease in people with obstructive sleep apnea regardless of CPAP use, suggests a new study from Columbia University.
After a sudden medical scare, many people develop a fear of health care and are afraid to adopt new health habits. The Center for Fearless Behavior Change is testing ways to help.
Iok In Christine Chio, PhD, and Oliver Clarke, PhD, early-career investigators at VP&S, are 2023 recipients of prestigious awards from the Irma T. Hirschl Trust Research Scientist Program.
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
Columbia’s cell therapy lab, which creates customized cell therapies, is testing its first product, T cells trained to fight dangerous infections in transplant patients.
Commonly used drugs that reduce joint inflammation in patients with rheumatoid arthritis also reduce vascular inflammation and cardiovascular risk, finds a new study from Columbia University.
A recent rise in a rare lymphoma has been linked to breast implants, but Columbia researchers have found that the risk is extremely low among women who have reconstructive surgery after mastectomy.
Columbia's Clinical Innovation Lab, a hub that helps doctors develop new technologies to improve patient care, has already funded five projects. Yours could be next.
The diminished power of the immune system in older adults is usually blamed on the aging process. A new study shows that decades of inhaled particulates due to air pollution also take a toll.
An implantable pump that has the potential to transform brain cancer treatment was found safe and effective in people in a study at Columbia University.
Ghosh was elected for his elected for his pioneering studies of the immune system and establishing strategies for the treatment of inflammatory diseases and cancer.